植物來源疫苗市場：按疫苗類型、來源、應用和地區分類

Plant-based Vaccines Market, By Vaccine Type, By Source, By Application, By Geography

出版日期: 2023年10月17日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2023 年，全球植物來源疫苗市場價值將達到 9,590 萬美元，預計在預測期內（2023-2030 年）年複合成長率為 51.3%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	9590萬美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	51.30%	2030年市場規模預測	17.391 億美元

圖 1. 2023 年植物來源的全球市場佔有率(%)，依應用分類

疫苗是減輕感染疾病負擔最具成本效益和最有效的手段。人們不斷尋求新的方法來提高產品品質和可近性，同時降低製造成本。傳統上，疫苗使用病原體的弱化版本，或致病生物體或其適當部分（例如毒素）的製備和去活化，並以足夠的量給藥以誘導免疫。不可避免的可能性是，此類疫苗可能被可感染此類物質的不確定物質污染。一種令人興奮的新可能性是在基因改造植物中生產疫苗抗原，並使用傳統方法提取和精製它們。此類疫苗可以食用或塗布黏膜表面。植物來源有幾個優點。它們能夠被患者耐受，價格便宜並且可以大量生產，並且所得抗原穩定並且可以長期保存。植物病毒污染不太可能對人類產生任何負面影響。為了使植物來源疫苗廣泛使用，必須解決一些技術挑戰，並且必須制定此類新型疫苗的法規要求。此外，這項新技術必須被廣泛接受。

市場動態

市場主要企業增加產品推出預計將在預測期內推動全球植物來源疫苗市場的成長。例如，2022年12月，化學公司贏創宣布推出植物來源角鯊烯，可提高疫苗的效力。 PhytoSquene 是第一個已知的源自莧菜油的角鯊烯，可用作腸胃外劑型的佐劑。這是為了滿足對非動物源角鯊烯的穩定商業性供應的需求。

本研究的主要特點

本報告對全球植物來源市場進行了詳細分析，並提出了以2022年為基準年的預測期（2023-2030）的市場規模和複合年度（年複合成長率）。
它還闡明了不同細分市場的潛在收益成長機會，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球植物來源疫苗市場的主要企業。
受調查的主要公司包括 Medicago, Inc.、IBIO, Inc.、Icon Genetics GmbH、Lumen Bioscience, Inc.、英美菸草公司、Creative Biolabs, Inc.、Leaf Expression Systems Ltd. 和 ZYUS Life Sciences Inc. PlantForm Corporation和傳染病研究所(IDRI)。
本報告中的見解將幫助行銷人員和公司負責人就未來的產品發布、經營團隊、市場擴張和行銷策略做出資訊的決策。
全球植物來源疫苗市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球植物來源疫苗市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 95.9 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	51.30%	2030 Value Projection:	US$ 1,739.1 Mn

Vaccines are the most cost-effective and efficacious means of reducing the disease burden of infectious diseases. Novel approaches to improve product quality and improve access while lowering production costs are continuously sought. Traditionally, vaccines are prepared by using an attenuated version of the pathogen or by preparing and inactivating a disease-causing organism or a suitable part of it, e.g. a toxin, and administering it in quantities sufficient to induce immunity. Such vaccines have the unavoidable potential for contamination with adventitious agents that can infect such materials. A new and exciting possibility is the production of vaccine antigens in genetically modified plants, which can then be extracted and purified by conventional methods. Such vaccines could either be eaten or applied to mucosal surfaces. Plant-derived vaccines have several advantages. They are easily tolerated by patients, can be made cheaply in very large quantities, and the antigens obtained from them are stable and can be kept in storage for a very long time. The likelihood that contamination by a plant virus would have an adverse effect on humans is almost negligible. There are several technical challenges concerning plant-derived vaccines that must be resolved before they can enter wide-scale use, and the regulatory requirements for this novel class of vaccines must be established. In addition, public acceptance of the new technology must be ensured.

Market Dynamics

Increasing product launches by key players in the market are expected to drive the growth of the global plant-based vaccines market over the forecast period. For instance, in December 2022, Evonik, a chemical company, announced the launch of plant-based squalene to boost vaccine efficacy. PhytoSquene is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene.

Key features of the study:

This report provides an in-depth analysis of the global plant-based vaccines market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global plant-based vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, Inc., British American Tobacco Plc., Creative Biolabs, Inc., Leaf Expression Systems Ltd., ZYUS Life Sciences Inc., PlantForm Corporation, and Infectious Disease Research Institute (IDRI).
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global plant-based vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plant-based vaccines market

Global Plant-based Vaccines Market Detailed Segmentation:

By Vaccine Type:
- Bacterial Vaccines
- Viral Vaccines
- Parasite Vaccines
- Others
By Source:
- Tobacco Plant
- Maize
- Potato
- Others
By Application:
- Influenza
- COVID-19
- Zika Virus
- Ebola Virus
- Poultry Disease
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Medicago, Inc.
- IBIO, Inc.
- Icon Genetics GmbH
- Lumen Bioscience, Inc.
- British American Tobacco Plc.
- Creative Biolabs, Inc.
- Leaf Expression Systems Ltd.
- ZYUS Life Sciences Inc.
- PlantForm Corporation
- Infectious Disease Research Institute (IDRI)

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Source
- Market Snippet, By Application
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Plant-based Vaccines Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Plant-based Vaccines Market, By Vaccine Type, 2018-2030, (US$ Mn )

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Bacterial Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn )
- Segment Trends
Viral Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
Parasite Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends

6. Global Plant-based Vaccines Market, By Source, 2018-2030, (US$ Mn )

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Tobacco Plant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
Maize
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
Potato
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
- Segment Trends

7. Global Plant-based Vaccines Market, By Application, 2018-2030, (US$ Mn )

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
Covid-19
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
Zika Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
Ebola Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
Poultry Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn )

8. Global Plant-based Vaccines Market, By Region, 2018-2030, (US$ Mn )

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018 - 2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn )
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Vaccine Type, 2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Source,2018-2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn )
- Market Size and Forecast, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Mn )
North Africa
Central Africa
South Africa